4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-059290
Director sold 2,000 shares at an average $47.69 ($95,381)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-11-16 | Option exercise | +2,000 | $0.45 | $900 | 2,000 | D |
| HERSHBERG ROBERT Director | 2020-11-16 | Sale | −1,777 | $47.60 | $84,585 | 223 | D |
| HERSHBERG ROBERT Director | 2020-11-16 | Sale | −223 | $48.41 | $10,795 | 0 | D |
| Derivatives | |||||||
| HERSHBERG ROBERT Director | 2020-11-16 | Option exercise · Stock Option (Right to Buy) | −2,000 | 61,000 | D | ||
| Open-market sales · 2,000 sh · avg $47.69 · $95,381 | |||||||
Loading xslF345X03/doc4.xml…